PHILADELPHIA--Michael Goldberg M.D. and Shepard M. Goldberg, both recently elected board members of Echo Therapeutics (Nasdaq:ECTE), will host a conference call with investors to discuss recent developments and purchase cialis cheap also their goals to establish a new strategic direction for the company which will require the removal of the three predecessor directors for cause.
BURLINGTON, Mass.--LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and cialis canada implants, announced today that on September 17, 2014 it acquired the angioscope product line from Applied Medical, Inc. for $420,000.
SAN DIEGO--Medical Marijuana Inc.'s (OTC Pink:MJNA) HempMeds™ – a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and viagra contracted marketing company for Medical Marijuana, Inc. – announced from Expo East significant advances for both the cannabis and cheap cialis without prescription natural products industry with the public launch of its cannabidiol (CBD)-rich hemp oil infused natural products retail and alternative for viagra pet nutrition lines: aNew Brands.
ENOLA, PA.--The National Sexual Violence Resource Center announces a multi-year partnership with the National Football League to address the far-reaching impacts of sexual assault and propecia canadian pharmacy domestic violence.
MENLO PARK, Calif.--Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a clinical-stage biotechnology company focused on discovering and viagra for women developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases, today announced that Thomas W. Chalberg, Jr., Ph.D., Founder and viagra en gel Chief Executive Officer, will present at the 21st Annual NewsMakers in the Biotech Industry conference on Friday, September 26, 2014 at 10:30 AM (EDT) in New York, NY.
DURHAM, N.C.--Argos Therapeutics, Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and overnight canadian viagra commercialization of fully personalized immunotherapies for the treatment of cancer and canadian viagra 50mg infectious diseases using its Arcelis® technology platform, today announced that Jeff Abbey, president and cheap canadian viagra chief executive officer, will present at the 21st Annual BioCentury NewsMakers Conference on Friday, September 26, 2014 at 2:00 p.m. Eastern Time.
CAMBRIDGE, Mass.--Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced it will present clinical data on three novel antibody cancer therapeutics at the ESMO (European Society for Medical Oncology) 2014 Congress, September 26-30 in Madrid. Presentations will include a combined biomarker analysis of MM-121 across three Phase 2 studies, MM-111 Phase 1 biomarker data and updated Phase 1 safety and clinical activity for MM-151.
BERKELEY HEIGHTS, N.J.--Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that the Company will present at BioCentury's Newsmakers in the Biotech Industry Conference being held at the Millennium Broadway Hotel & Conference Center, New York, NY.